Patient Specific Instrumentation Potentially Expedites European Knee Replacement Procedures

By Zimmer Holdings Inc., PRNE
Wednesday, June 1, 2011

COPENHAGEN, Denmark, June 2, 2011 -

- Introduction of Zimmer(R) Patient Specific Instruments for European

Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in
musculoskeletal care, is showcasing its Zimmer Patient Specific Instruments
(PSI) at the 12th annual European Federation of National Associations of
Orthopaedics and Traumatology (EFORT) meeting in Copenhagen, Denmark.

Zimmer Patient Specific Instruments utilize MRI technology and
pre-operative planning tools to create customized pin guides that are
tailored to each patient's unique anatomy. Customized guides for knee
replacement surgery support surgeons in performing accurate and safe
procedures. Zimmer PSI may be used in minimally-invasive procedures.

"Zimmer Patient Specific Instruments can assist in expediting the total
knee replacement procedure for both surgeons and patients," said Jeff
, President, Zimmer Reconstructive. "This technology has been well
received in the United States and we are excited to now make these
instruments available to surgeons in Europe."

Zimmer PSI are designed to ensure accurate placement of the knee implant
and are compatible with the Zimmer(R) NexGen(R) Complete Knee Solution and
the Gender Solutions(R) Natural Knee(R)(R) Flex systems. Zimmer PSI
streamline the surgical procedure, eliminating several steps in the total
knee replacement procedure and potentially increase efficiency in the
operating room.

For more information on Zimmer Patient Specific Instruments, visit the
Zimmer booth at EFORT or go to

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs,
develops, manufactures and markets orthopaedic reconstructive, spinal and
trauma devices, dental implants, and related surgical products. Zimmer has
operations in more than 25 countries around the world and sells products in
more than 100 countries. Zimmer's 2010 sales were approximately $4.2 billion.
The Company is supported by the efforts of more than 8,000 employees

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995
based on current expectations, estimates, forecasts and projections about the
orthopaedics industry, management's beliefs and assumptions made by
management. Forward-looking statements may be identified by the use of
forward-looking terms such as "may," "will," "expects," "believes,"
"anticipates," "plans," "estimates," "projects," "assumes," "guides,"
"targets," "forecasts," and "seeks" or the negative of such terms or other
variations on such terms or comparable terminology. These statements are not
guarantees of future performance and involve risks, uncertainties and
assumptions that could cause actual outcomes and results to differ
materially. For a list and description of such risks and uncertainties, see
our periodic reports filed with the U.S. Securities and Exchange Commission.
We disclaim any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise, except as may be set forth in our periodic reports.
Readers of this document are cautioned not to place undue reliance on these
forward-looking statements, since, while we believe the assumptions on which
the forward-looking statements are based are reasonable, there can be no
assurance that these forward-looking statements will prove to be accurate.
This cautionary statement is applicable to all forward-looking statements
contained in this document.

Media: Garry R. Clark, +1-574-372-4493, garry.clark at; or Investors: Robert J. Marshall Jr., +1-574-371-8042, robert.marshall. at

will not be displayed